Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
Go back to Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases| Asianada, Inc. (NASDAQ: ASND) | Delayed: 238.35 +1.63 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.72 | 52 Week High | $21.79 | |||
| Open | $238.66 | 52 Week Low | $11.92 | |||
| Day High | $241.51 | P/E | N/A | |||
| Day Low | $237.50 | EPS | $-0.07 | |||
| Volume | 351,961 | |||||

